The initiative aims to resolve discrepancies in the Central Drugs Standard Control Organisation’s database and create a ...
From sequencing decisions to economics of care, Adam Kittai, MD, offers a wide-ranging look at top unresolved questions in CLL treatment today. He also explored when a triplet regimen—acalabrutinib, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results